Last reviewed · How we verify
PXL01
At a glance
| Generic name | PXL01 |
|---|---|
| Sponsor | PharmaSurgics AB |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study of PXL01 Versus Placebo to Inhibit Adhesion Formation After Flexor Tendon Surgery (PHASE2)
- Safety Study Investigating Local Tolerability and Pharmacokinetics of PXL01 in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PXL01 CI brief — competitive landscape report
- PXL01 updates RSS · CI watch RSS
- PharmaSurgics AB portfolio CI